Planning consent for global headquarters

Planning consent for global headquarters

Feb 5, 2015  | Architecture 

Planning consent for global headquarters
(Photo by: BDP)

AstraZeneca has announced that Cambridge City Council has granted planning permission for its new global R&D centre and corporate headquarters.

BDP is the lead consultant for the £330m building which will be home for approximately 2,000 employees who will be located on the Cambridge Biomedical Campus. BDP is also responsible for the executive architecture, combined engineering, landscape, interiors, acoustics and specialist lighting services and for delivering concept architect Herzog & de Meuron’s vision.

The new facility will support AstraZeneca’s drive for scientific leadership by investing in Cambridge, one of the world’s pre-eminent biosciences hotspots. A central hub of labs will form the focal point for the centre, which will encourage collaborative working across the organisation and provide easy access for the wider scientific community through an open design and campus environment.

Mene Pangalos, Executive Vice President, Innovative Medicines & Early Development at AstraZeneca said: “We are very pleased with today’s decision by Cambridge City Council. Work is underway to prepare the site on the Cambridge Biomedical Campus and we look forward to beginning construction in the spring. Our aim is to create an open, welcoming and vibrant centre that will inspire our teams and partners to push the boundaries of scientific innovation for the benefit of patients.”

Via BDP
Image,video ©: BDP